LASER VERSUS CRYSTALLIZED PHENOL IN PILONIDAL SINUS DISEASE

Starting soon · Not applicable

Conditions studied: Sacrococcygeal Pilonidal Sinus Disease, Pilonidal Sinus Disease

In brief

This single-center prospective randomized parallel-group trial compares laser ablation and crystallized phenol application in adults with primary uncomplicated sacrococcygeal pilonidal sinus disease. The primary objective is to compare postoperative day 1 pain intensity between the two treatment methods. Secondary objectives include complete epithelialization by day 30, time to complete epithelialization, postoperative day 7 pain, duration of analgesic use, time to return to daily activities and work, early local complications, and 6-month recurrence.

Key facts

Study ID

NCT07701772

Run by

Sanliurfa Education and Research Hospital

People needed

120

Starts

2026-07-15

Expected to finish

2027-03-01

Last updated by the study team

2026-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• Diagnosis of primary chronic sacrococcygeal pilonidal sinus disease
• Uncomplicated disease
• Suitability for minimally invasive treatment
• Provision of written informed consent

You may not qualify if…

• Acute pilonidal abscess
• History of pilonidal abscess drainage
• Previous surgical or interventional treatment for pilonidal sinus disease
• Recurrent pilonidal disease
• Complex pilonidal disease or marked lateral extension
• Immunosuppression, chronic steroid use, or systemic conditions that may significantly impair wound healing
• Inability to attend regular follow-up
• Refusal to participate in the study

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.